Literature DB >> 2348424

Pharmacokinetics of auranofin a single dose study in man.

H P Benn1, C Schnier, K U Seiler, E Bauer, H Löffler.   

Abstract

Three days after cholecystectomy 7 patients were given a single dose of auranofin (5 tablets Ridaura = 4.35 mg gold). Gold was detected in samples of blood, plasma, urine, bile and feces. The determinations were carried out using instrumental neutron activation analysis. The mean gold concentrations reached maximum in blood and plasma after 2 h and in urine and bile after 16 h. The mean terminal half-lives were 7.6 days (blood), 15 days (plasma) and 6.5 days (bile). Cumulative amounts of gold excreted in bile, urine, and feces were 1.6, 4 and 40%, respectively.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348424

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  2 in total

Review 1.  Clinical pharmacokinetics of slow-acting antirheumatic drugs.

Authors:  S E Tett
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447

2.  Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.

Authors:  Arya Sobhakumari; Laurie Love-Homan; Elise V M Fletcher; Sean M Martin; Arlene D Parsons; Douglas R Spitz; C Michael Knudson; Andrean L Simons
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.